Tagged with IPO

5 Top Trends in Chinese Healthcare & Biopharma in 2020
China Biopharma Dealmaking 2020 Review
2020’s Top 7 Biotech IPOs in Profile
China: 2020’s Biggest Biotech IPO in Profile
HKEX SVP Reflects on Two Years of Pre-Revenue Biotech IPO Listings in Hong Kong
Hong Kong Biotech IPOs since Listing Reform in April 2018
China Pharma News Roundup July 24th 2020
SCM Lifescience: A Global Approach to Korean Regenerative Medicine
Michael Chan – Senior Vice President, Global Issuer Services, Hong Kong Exchanges and Clearing Limited (HKEX)
Xu Ting – Founder, Chairman & CEO, Alphamab Oncology, China
5 Cell & Gene Companies to Watch in South Korea
Jingsong Wang – Chairman & CEO, Harbour BioMed, China
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here